Kim Hoffman

Kim Hoffman is a Senior Professor at Oregon Health & Science University, where her research focuses on addiction medicine, public health, and health policy, with a particular emphasis on opioid use disorder, substance use disorders, and emerging treatments. Her recent work explores the ethical complexities of informed consent for psychedelic services, the development of Oregon’s legal psilocybin facilitator workforce, and best-practice indicators for psilocybin-assisted therapy. She also investigates peer-delivered interventions, including contingency management for harm reduction and shared decision-making for buprenorphine transitions, alongside rural community partnerships addressing methamphetamine-associated heart failure and peer-assisted telemedicine for hepatitis-C treatment. Her publications span venues such as *Harm Reduction Journal*, *Addiction Science & Clinical Practice*, and *Drug and Alcohol Dependence Reports*, reflecting her commitment to advancing equitable, community-centered addiction care.